Mohammed VI Foundation for Science and Health and IAEA sign strategic cooperation agreement in Vienna
via Le Matin1 min read
The Mohammed VI Foundation for Science and Health FM6SS and the International Atomic Energy Agency IAEA have signed a strategic cooperation agreement in Vienna. This partnership aims to enhance international collaborations in health, focusing on areas such as radiotherapeutic oncology, medical imaging, nuclear medicine, medical physics, and nutrition. The agreement emphasizes sharing expertise, developing skills, supporting research, and continuously improving healthcare quality. FM6SS will actively contribute to IAEA's international initiatives, including training programs, expert missions, and supporting projects like "Rays of Hope." This collaboration will also facilitate the hosting of international talent and strengthen contributions to global efforts for low and middle-income countries. The agreement is seen as a strategic tool to consolidate expertise, stimulate health innovation, and position Morocco as a regional hub in medical sciences. The signing was accompanied by a visit to IAEA laboratories, showcasing advanced technologies and research programs. This alliance underscores the shared commitment of FM6SS and IAEA to impactful cooperation for healthcare systems and patient well-being.
Free daily or weekly digest of the most important stories from across 10 countries. No spam, unsubscribe any time.
This summary was AI-generated from a story originally published by Le Matin.
Luxembourg's Minister of the Economy, SMEs, Energy and Tourism, Lex Delles, will lead a high-level economic delegation to Morocco from May 4 to 7, 2026. This mission aims to strengthen the already robust economic ties between the two nations. The delegation will include the Luxembourg Chamber of Commerce and approximately twenty companies from various sectors, seeking to foster direct exchanges with Moroccan partners and identify new investment opportunities. This comes as Morocco sees an increase in structuring projects, particularly in infrastructure, industry, and telecommunications. Luxembourg is among the top ten foreign investors in Morocco, while Morocco is a dynamic partner for the Grand Duchy in Africa. A Morocco-Luxembourg Economic Forum will be held on May 5, 2026, in partnership with the General Confederation of Moroccan Enterprises CGEM, bringing together business leaders to discuss joint investment projects and concrete collaborations. This visit marks the fourth major official mission between the two countries in less than ten years, underscoring their shared commitment to a long-term economic partnership based on mutual interests.
Mediterrania Capital Partners MCP has acquired Amcor Flexibles Mohammedia AFM, a Moroccan company specializing in flexible packaging solutions. Located in Mohammedia, AFM manufactures packaging for the dairy, pharmaceutical, food, and hygiene industries. The company has an industrial heritage dating back to 1949 and has been part of the Amcor group since 2010. MCP's acquisition aligns with its strategy to invest in leading mid-sized African companies to support their growth. MCP highlights AFM's potential for diversifying its offerings and client base within a resilient sector. The new shareholder plans to build upon AFM's achievements under Amcor, accelerate growth through targeted investments, improve operational efficiency, and strengthen governance. Maintaining high safety and quality standards is also a priority. MCP intends to collaborate with existing management to expand production capacity, broaden product offerings, and diversify the client portfolio, aiming to position AFM as a leading industrial platform for flexible packaging in Morocco and the wider region. With over 1.2 billion euros in assets under management and a presence in various African and international hubs, Mediterrania Capital Partners is expanding its industrial footprint in Morocco. This transaction underscores Morocco's appeal to international investors and the growing role of private equity in transforming the national industrial landscape.
Attijariwafa bank, the National Interprofessional Office of Cereals and Legumes ONICL, and the National Federation of Milling FNM have signed a partnership agreement during the 17th International Agricultural Show in Morocco SIAM. The collaboration aims to provide financial support to industrial millers, particularly those producing subsidized soft wheat flour, by addressing their cash flow challenges. The new mechanism allows eligible operators to anticipate public compensation payments through bank financing, thereby reducing payment delays and improving liquidity. This initiative is designed to help millers secure their industrial operations amidst volatile agricultural markets. Attijariwafa bank views this as part of its strategy to support the real economy and finance strategic sectors. ONICL strengthens its role as a market regulator, contributing to the compensation system's fluidity and national supply stability. FNM enhances its support for millers by facilitating access to financial tools. The partnership also includes plans for the future simplification and digitalization of processes to improve efficiency, transparency, and the experience of industry stakeholders. This collaboration is expected to positively impact the financial stability of millers, preserve jobs, and ensure the consistent production of subsidized flour, aligning with Morocco's food security objectives.
Medicine is shifting from observational approaches to individualized care, driven by precision medicine and a deeper understanding of molecular mechanisms and patient biological profiles. This transformation is the central theme of the National Pathology Congress 2026 in Rabat, bringing together experts in anatomical pathology, medical biology, and oncology. Professor Basma El Khanoussi, president of the congress, emphasizes the need to unify stakeholders, update practices, and fully integrate precision medicine, creating a common language among pathologists, molecular pathologists, and clinicians for more refined and personalized disease interpretation. This marks a move from descriptive to decisional pathology, with pathologists directly involved in therapeutic choices and patient follow-up. Molecular pathology is key, identifying targetable alterations and prognostic indicators, making diagnosis a "therapeutic passport." The pathologist's role evolves into an integrative expert, combining morphological and molecular data with decision-making tools. Artificial intelligence supports this by improving reproducibility, refining anomaly detection, and managing workflows, enhancing human expertise rather than replacing it. Digital pathology is also a major focus, offering tele-diagnosis, expertise sharing, and distance learning, despite technical, regulatory, and financial hurdles. The congress program includes sessions on HER2-low breast cancers, advances in colorectal cancer w